Abstract
Introduction: Vulvar cancer is a rare disease and accounts for 3-5% of all gynecological malignancies. The prognosis is related to lymph node involvement and stage. Surgery is the treatment cornerstone and includes primary tumor resection and inguinofemoral lymphadenectomy. Despite on clinical and pathological prognostic factors already described, some molecular markers are scarce. The id…